Literature DB >> 29120973

Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update.

Simona Pichini1, Renata Solimini1, Paolo Berretta1, Roberta Pacifici1, Francesco Paolo Busardò2.   

Abstract

Illicit fentanyl and its analogues are very dangerous synthetic opioids, with high abuse potential and severe adverse effects including coma and death. They are used as adulterants in street heroin, cocaine, and methamphetamine, or as heroin substitutes sold to unaware users with a high risk of overdoses. Fentanyl and its analogues have also been identified in counterfeit medicinal products, such as oxycodone, hydrocodone, and alprazolam tablets, or as components of speedball mixtures together with cocaine or other stimulants. In recent years, a number of epidemics involving acute intoxications and deaths related to illicit fentanyl or its analogues have occurred in the United States, Europe, Canada, Australia, and Japan. In several cases, fatalities involved polysubstance use. A review of the most recent case reports or case series of acute intoxications and fatalities involving illicit fentanyl and its newest analogues is herein provided, together with the available information on intoxication symptoms, eventual death cause, and metabolites detected in different biological fluids and reported concentrations.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29120973     DOI: 10.1097/FTD.0000000000000465

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  24 in total

1.  Evidence for nonlinear accumulation of the ultrapotent fentanyl analog, carfentanil, after systemic administration to male rats.

Authors:  Marianne Skov-Skov Bergh; Inger Lise Bogen; Nancy Garibay; Michael H Baumann
Journal:  Neuropharmacology       Date:  2019-04-06       Impact factor: 5.250

2.  Barriers to accurately assessing prescription opioid misuse on surveys.

Authors:  Joseph J Palamar
Journal:  Am J Drug Alcohol Abuse       Date:  2018-09-19       Impact factor: 3.829

3.  Toward the Interpretation of Positive Testing for Fentanyl and Its Analogs in Real Hair Samples: Preliminary Considerations.

Authors:  A Salomone; R Bigiarini; J J Palamar; C McKnight; L Vinsick; E Amante; D Di Corcia; M Vincenti
Journal:  J Anal Toxicol       Date:  2020-05-18       Impact factor: 3.367

4.  Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis.

Authors:  Theodore J Cicero; Matthew S Ellis; Zachary A Kasper
Journal:  Am J Public Health       Date:  2019-12-19       Impact factor: 9.308

Review 5.  Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment.

Authors:  Sandra D Comer; Catherine M Cahill
Journal:  Neurosci Biobehav Rev       Date:  2018-12-05       Impact factor: 8.989

6.  Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.

Authors:  Ju Nyeong Park; Saba Rouhani; Leo Beletsky; Louise Vincent; Brendan Saloner; Susan G Sherman
Journal:  Milbank Q       Date:  2020-08-18       Impact factor: 4.911

7.  Willingness to provide a hair sample for drug testing among electronic dance music party attendees.

Authors:  Joseph J Palamar; Alberto Salomone; Charles M Cleland; Scott Sherman
Journal:  Subst Abus       Date:  2018-08-17       Impact factor: 3.716

8.  A synthetic opioid vaccine attenuates fentanyl-vs-food choice in male and female rhesus monkeys.

Authors:  E Andrew Townsend; Paul T Bremer; Nicholas T Jacob; S Stevens Negus; Kim D Janda; Matthew L Banks
Journal:  Drug Alcohol Depend       Date:  2020-10-20       Impact factor: 4.492

9.  Differences in Opioid Overdose Mortality Rates Among Middle-Aged Adults by Race/Ethnicity and Sex, 1999-2018.

Authors:  Rachel A Hoopsick; Gregory G Homish; Kenneth E Leonard
Journal:  Public Health Rep       Date:  2020-11-19       Impact factor: 2.792

10.  Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances.

Authors:  Valeria Sogos; Paola Caria; Clara Porcedda; Rafaela Mostallino; Franca Piras; Cristina Miliano; Maria Antonietta De Luca; M Paola Castelli
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.